反应详情

The title compound was prepared following the procedure of Example 1 with N5-(2-chloropyrimidin-4-yl)-N2,N5,1-trimethyl-1H-benzimidazole-2,5-diamine (58 mg, 0.20 mmol) and 5-amino-2-methyl-benzenesulfonamide (35 mg, 0.20 mmol) as a pink solid (78 mg, 84%). 1H NMR (300 MHz, d6-DMSO) δ 10.63 (br s, 1H), 9.22 (d, J=4.2 Hz, 1H), 8.40 (br s, 2H), 7.91 (d, J=6.9 Hz, 1H), 7.67 (m, 2H), 7.47 (d, J=1.5 Hz, 1H), 7.28-7.36 (m, 3H), 5.83 (m, 1H), 3.67 (s, 3H), 3.53 (s, 3H), 3.08 (d, J=4.5 Hz, 3H), 2.54 (s, 3H). MS (ESI) m/z=453 [M+H]+.